Literature DB >> 25202106

Elderly women above screening age diagnosed with cervical cancer have a worse prognosis.

Lotten Darlin1, Christer Borgfeldt2, Emelie Widén2, Päivi Kannisto2.   

Abstract

AIM: To analyze the cervical screening history in women with cervical cancer and their outcome.
DESIGN: All women diagnosed with cervical cancer between January 2009 and December 2010 in the South Sweden region were included in the audit.
MATERIALS AND METHODS: Cervical cancer was registered in 165 women in 2009 and 2010. Their screening history was analyzed, and was classified as normal or imperfect. The method of discovering the cancer was either by symptoms or by screening. The main outcome measured was overall survival in cervical cancer related to cervical screening history.
RESULTS: Women above 65 years of age were more frequently diagnosed with advanced-stage disease (The International Federation of Gynecology and Obstetrics II-IV) (n=36 out of 43; 84%) compared to women below 65 years of age (n=35 out of 122; 29%) (p<0.001). All patients diagnosed by the cervical screening program were still alive (30/30) at the median follow-up time (36 months), showing better overall survival compared to women below screening age in whom cancer was discovered due to symptoms (68/98; p<0.001). Cox proportional hazards model showed that women beyond screening age (>65 years old) with normal screening history had a worse prognosis, with a hazard ratio of 4.8 (95% confidence interval=1.9-12.1, p=0.001), and women (>65 years old) who had not followed the screening program had a hazard ratio of 5.9 (95% confidence interval I 2.4-14.6, p<0.001), compared to women under 65 years old who had followed the screening program.
CONCLUSION: Cervical cancer in women above the age of 65 years is discovered at advanced stages of the disease and their prognosis is poor. Copyright
© 2014 International Institute of Anticancer Research (Dr. John G. Delinassios), All rights reserved.

Entities:  

Keywords:  Cervical screening program; HPV test; Swedish population; cervical cancer; overall survival

Mesh:

Year:  2014        PMID: 25202106

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  15 in total

1.  'I Want the Whole Package'. Elderly Patients' Preferences for Follow-Up After Abnormal Cervical Test Results: A Qualitative Study.

Authors:  Pia Kirkegaard; Line Winther Gustafson; Lone Kjeld Petersen; Berit Andersen
Journal:  Patient Prefer Adherence       Date:  2020-07-12       Impact factor: 2.711

2.  Racial/Ethnic Differences Affecting Adherence to Cancer Screening Guidelines Among Women.

Authors:  Jacqueline M Hirth; Tabassum Haque Laz; Mahbubur Rahman; Abbey B Berenson
Journal:  J Womens Health (Larchmt)       Date:  2015-11-18       Impact factor: 2.681

3.  Changing trends in the incidence (1999-2011) and mortality (1983-2013) of cervical cancer in the Republic of Korea.

Authors:  Yoon Park; Champadeng Vongdala; Jeongseon Kim; Moran Ki
Journal:  Epidemiol Health       Date:  2015-05-29

4.  HPV prevalence and HPV-related dysplasia in elderly women.

Authors:  Ruth S Hermansson; Matts Olovsson; Emelie Hoxell; Annika K Lindström
Journal:  PLoS One       Date:  2018-01-10       Impact factor: 3.240

5.  Cervical dysplasia in elderly women performing repeated self-sampling for HPV testing.

Authors:  Annika Kristina Lindström; Ruth Sanchez Hermansson; Inger Gustavsson; Julia Hedlund Lindberg; Ulf Gyllensten; Matts Olovsson
Journal:  PLoS One       Date:  2018-12-05       Impact factor: 3.240

6.  HPV-based screening for cervical cancer among women 55-59 years of age.

Authors:  Lovisa Bergengren; Gabriella Lillsunde-Larsson; Gisela Helenius; Mats G Karlsson
Journal:  PLoS One       Date:  2019-06-14       Impact factor: 3.240

7.  Effectiveness of cervical cancer screening at age 65 - A register-based cohort study.

Authors:  Maiju Pankakoski; Ahti Anttila; Tytti Sarkeala; Sirpa Heinävaara
Journal:  PLoS One       Date:  2019-03-26       Impact factor: 3.240

8.  Elderly women's experiences of self-sampling for HPV testing.

Authors:  Ruth S Hermansson; Matts Olovsson; Catharina Gustavsson; Annika Kristina Lindström
Journal:  BMC Cancer       Date:  2020-05-26       Impact factor: 4.430

9.  Cervical Cancer Histology, Staging and Survival before and after Implementation of Organised Cervical Screening Programme in Poland.

Authors:  Andrzej Nowakowski; Marek Cybulski; Irmina Buda; Iwona Janosz; Katarzyna Olszak-Wąsik; Piotr Bodzek; Andrzej Śliwczyński; Zbigniew Teter; Anita Olejek; Włodzimierz Baranowski
Journal:  PLoS One       Date:  2016-05-19       Impact factor: 3.240

Review 10.  The Complementary Role of Imaging and Tumor Biomarkerszzm321990in Gynecological Cancers: An Update of the Literature

Authors:  Emanuela Anastasi; Silvia Gigli; Laura Ballesio; Antonio Angeloni; Lucia Manganaro
Journal:  Asian Pac J Cancer Prev       Date:  2018-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.